EXPE vs NDRA · P/E 20, rev $13.69B vs P/E 0.0, $2.6M cap
Expedia Group Inc. (EXPE) versus ENDRA Life Sciences Inc (NDRA) — a side-by-side from cached financials, not a winner call.
Expedia Group Inc. (EXPE) is a travel services company listed on US.
ENDRA Life Sciences Inc (NDRA) is a diagnostics & research company listed on US.
Latest reported EXPE revenue for 2024-12-31 was $13.69B. Net income was $1.22B. Revenue was up 6.6% from 2023-12-31 to 2024-12-31. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
NDRA does not have a complete income-statement cache yet.
EXPE currently screens at market cap $21.71B and trailing P/E 20.4. NDRA currently screens at market cap $2.6M and trailing P/E 0.0.
Not investment advice. Open the EXPE and NDRA stock pages for the full models.
Not investment advice.